A raised level of C-reactive protein (CRP) has been found to be an indicator of poor prognosis in several cancers, including esophageal carcinoma, carcinoma of the stomach, colorectal cancer, hepatocellular carcinoma, renal cancer, and pancreatic tumor [8,9,10,11]. This evidence concerns the gene CRP and hepatocellular carcinoma.